Patients with COVID-19 Critical Illness Have a Significantly Higher Systemic Immune-Inflammatory Index on Admission

Fenty Fenty; Dita Maria Virginia; I Made Adi Ananda Putra; Devie Kristiani; Lisa Kuniasari

doi:10.24071/jpsc.005150

Patients with COVID-19 Critical Illness Have a Significantly Higher Systemic Immune-Inflammatory Index on Admission

Fenty Fenty^(1*), Dita Maria Virginia⁽²⁾, I Made Adi Ananda Putra⁽³⁾, Devie Kristiani⁽⁴⁾, Lisa Kuniasari⁽⁵⁾,

(1) Faculty of Pharmacy, Sanata Dharma University, Campus III Paingan, Maguwoharjo, Depok, Sleman, Yogyakarta 55282, Indonesia
(2) Faculty of Pharmacy, Sanata Dharma University, Campus III Paingan, Maguwoharjo, Depok, Sleman, Yogyakarta 55282, Indonesia
(3) Faculty of Pharmacy, Sanata Dharma University, Campus III Paingan, Maguwoharjo, Depok, Sleman, Yogyakarta 55282, Indonesia
(4) Bethesda Hospital, Yogyakarta, 55224, Indonesia
(5) Bethesda Hospital, Yogyakarta, 55224, Indonesia
(*) Corresponding Author

Abstract

The severity of Coronavirus Disease-2019 (COVID-19) has been correlated to the massive inflammatory response. Patients with COVID-19 have a higher inflammatory marker. The Systemic Immune-Inflammation Index (SII) can be considered as an indicator of the immune-inflammatory status. Many studies stated that SII could significantly indicate the severity of COVID-19. This research aimed to explore the admission SII score and its association with the severity of hospitalized patients with COVID-19. It was a cross-sectional observational study. Data were collected retrospectively from the electronic medical records (ERM) and Laboratory Information System (LIS). The severity of COVID-19 and laboratory data on admission were analyzed. There were 180 patients (49.4% males and 50.6% female) with COVID-19 included in this research. Of these 180 patients, 22. 8% were categorized as mild, 18.9 moderate, 37.2% severe, and 21.1% were critical cases. Patients with critical illness had significantly higher SII scores than other groups with a p-value < 0.05. SII on admission could be a noticeable predictor of the occurrence of critically ill COVID-19 patients.

Keywords

Critical condition; COVID-19; Systemic Immune-Inflammation Index; SII

Full Text:

PDF

References

Adi, I.M.A.A., Fenty, 2022. Hubungan Komorbiditas terhadap Derajat Keparahan Admisi dan Outcome Pasien COVID-19. Journal of Health Promotion and Service Management, 1(1):11-18.

Barrett,T.J., Bilaloglu, S., Cornwell, M., Burgess, H.M., Virginio, V.W., Drenkova, K., et.al., 2021. Platelets contribute to disease severity in COVID-19. J. Thromb. Haemost., 19(12):3139-315.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., et al., 2020. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 395:507–13.

Doganci, S., Ince, M., Ors, N., Yildirim, A., Sir, E., Karabacak, K.A., et al.,2020. New COVID-19 Prediction Scoring Model for in-Hospital Mortality: Experiences from Turkey, Single-Center Retrospective Cohort Analysis. Eur. Rev. Med. Pharmacol. Sci., 24(19):10247–57.

Fois, A.G., Paliogiannis, P., Scano, V., Cau, S., Babudieri, S., Perra, R., et al., 2020.The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients. Molecules, 25(5725):1-13.

Guan, W.J., Ni, Z.Y., Hu,Y., Liang, W.H., Ou, C.Q., He,.. JX, et al., 2020. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med., 382:1708– 20.

Henry, B.M., Cheruiyot, I., Vikse, J., Mutua, V., Kipkorir, V., Benoit,J., et al., 2020. Lymphopenia and Neutrophilia at Admission Predicts Severity and Mortality in Patients with COVID-19: A Meta-Analysis. Acta Bio Medica, 91(3:e2020008):1-16.

Karimi, A., Shobeiri, P., Kulasinghe, A., Rezaei, N.,2021. Novel Systemic Inflammation Markers to Predict COVID-19 Prognosis. Frontiers in Immunology, 12(741061):1-11.

Kementerian Kesehatan Republik Indonesia, Situasi Terkini Perkembangan Coronavirus Disease (COVID-19). [WWW Document]. URL https://covid19.kemkes.go.id/situasi-infeksi-emerging/situasi-terkini-perkembangan-coronavirus-disease-covid-19-29-juli-2022. (accessed 29.07.22).

Khave,L. J., Zafari, P., Pirsalehi. A., Saalari, S., Baghestani, A., Akbari, ME., Bashash, D., 2021. Association Between Thrombocytopenia and Platelet Profile with Morbidity/Mortality of Severe and Non-severe COVID-19 Patients. Rev. Assoc. Med. Brass., 67(11): 1670-1675.

Li, H., Huang, J.B., Pan, W., Zhang, C., Chang, X.Y., Yang, B., 2020. Systemic Immune‐Inflammatory Index Predicts Prognosis of Patients with COVID‐19: A Retrospective Study. Research Square,10.21203(rs.3.rs-30701), v1:1-37.

Lippi, G., Plebani, M., Henry, B.M., 2020. Thrombocytopenia Is Associated with Severe coronavirus Disease 2019 (COVID-19) Infections: A Meta-analysis. Clinica Chimica Acta: International Journal of Clinical Chemistry, 506: 145–148.

Merad, M., Martin, J.C., 2020. Pathological Inflammation in Patients with COVID-19: A Key Role for Monocytes and Macrophages. Nat. Rev. Immunol., 20: 355–362.

Muhammad, S., Fischer, I., Naderi, S., Faghih, Jouibari, M., Abdolreza, S., et al., 2021. Systemic Inflammatory Index Is a Novel Predictor of Intubation Requirement and Mortality after SARS-CoV-2 Infection. Pathogens, 10(58):1-9.

Nalbant, A., Demirci, T., Kaya, T., Aydın, A., Altındiş, M., Güçlü, E., 2021. Can Prognostic Nutritional Index and Systemic Immune-Inflammatory Index Predict Disease Severity in COVID-19? Int. J. Clin. Pract.,17 (e14544):1-8.

Panigrahy, D., Gilligan,M.M., Huang, S., Gartung, A., Cortés-Puch, I., Sime, P. J., Phipps, R. P., Serhan, C. N., & Hammock, B. D., 2020. Inflammation Resolution: A Dual-Pronged Approach to Averting Cytokine Storms in COVID-19? Cancer Metastasis Reviews, 39(2): 337–340.

Sukrisman, L., Sinto, R., Priantono, D., 2021. Hematologic Profiles and Correlation Between Absolute Lymphocyte Count and Neutrophil/Lymphocyte Ratio with Markers of Inflammation of COVID-19 in an Indonesian National Referral Hospital. International Journal of General Medicine, 14: 6919–6924.

Tay, M.Z., Poh,C. M., Rénia, L., MacAry, P.A., Ng, L., 2020. The Trinity of COVID-19: Immunity, Inflammation and Intervention. Nature Reviews Immunology, 20(6): 363–374.

World Health Organization. COVID-19 Weekly Epidemiological Update. Geneva: World Health Organization; 2022. [WWW Document]. URL https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---22-june-2022 (accessed 01.08.22).

Xue, G., Gan, X., Wu, Z., Xie, D., Xiong, Y., Hua, L., et al., 2020. Novel Serological Biomarkers for Inflammation in Predicting Disease Severity in Patients With COVID-19. International Immunopharmacology. 89 (Pt A.107065): 1-9.

Zuo, Y., Yalavarthi, S., Shi, H., Gockman, K., Zuo, M., Madison, J.A., et al., 2020. Neutrophil Extracellular Traps in COVID-19. JCI Insight, 5(11):1-12.

Zhang, B., Zhou, X., Zhu, C., Feng, F., Qiu, Y., Feng, J., et al., 2020. Immune Phenotyping Based on Neutrophil-to-Lymphocyte Ratio and IgG Predicts Disease Severity and Outcome for Patients with COVID-19. Front. Mol. Biosci., Sec. Molecular Diagnostic and Therapeutics, 7(157): 1-7.

DOI: https://doi.org/10.24071/jpsc.005150